A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With Asthma

NCT02777827 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Abediterol 0.156 μg
DRUG: Abediterol 2.5 μg
DRUG: Abediterol 0.05 μg
DRUG: Abediterol 0.156 μg
DRUG: Abediterol 2.5 μg
OTHER: Placebo

Sponsor

AstraZeneca